0%

Our progress journal.

Stenting without X-rays: Nano4Imaging tools featured in new JACC study

21.05.2026

Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium

19.05.2026

Aliform wins MedTech World North America 2026 startup pitch competition

18.05.2026

How digital healthtech startups can gain investor trust: Pier interviewed by Luxinnovation

08.05.2026

niostem’s electrotrichogenic wearable device shows significant hair density gains in men with androgenetic alopecia

07.05.2026

Roel van Wegberg promoted to Partner

23.04.2026

Impactful capital in practice: Roel & Carmel on a Delfin podcast on impact investing

13.04.2026

Investing in health is not impact investing

25.03.2026

Vivalyx announces First-in-Human use of Vivalyx Omnisol® in kidney transplant clinical trial

17.03.2026

Portfolio company Corporis Medical begins patient enrolment in clinical investigation of Laprixa

16.03.2026

Psylaris: bringing VR-powered trauma therapy to Ukraine

26.02.2026

Carmel van den Berk joins the BVP Health team

25.02.2026

Turning scarcity into opportunity: a breakthrough for organ donation

10.02.2026

PectCof (NL) secures a positive EFSA scientific opinion for Dutch Gum as a novel food ingredient

27.01.2026

Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229

11.12.2025

Lely invests in Dutch scale-up Grassa

09.12.2025

Exit: Fortimedix Surgical acquired by Medtronic

01.12.2025

Curapath and Cristal Therapeutics Sign Co-Exclusive License of CliCr® Bioconjugation Platform

26.11.2025

Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers

13.11.2025

Qorium secures €22m investment to accelerate cultivated leather commercialisation

11.11.2025

Psylaris secures new investment to expand digital mental health solutions across Europe

22.10.2025

BVP 2024 Impact Report Now Available!

14.10.2025

ReSolved Technologies: “Confidence in the product and the partnership!”

06.10.2025

AVL Motion: “Aiming to solve the major challenge: labour shortages!”

02.09.2025

All Deep dive New deal Portfolio Team